Sensorion to Attend Two Conferences in June 2021
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the
Source: finanznachrichten.de